Your Article Summary
See Latest ArticlesPharmacologic Management of Isolated Low High-Density Lipoprotein Syndrome
American Journal of Therapeutics, 07/23/08
Bermudez et al. - Torcetrapib, a cholesteryl esters transfer protein inhibitor, represented a hope to raise this lipoprotein; however, all clinical trials on this drug had ceased after ILLUMINATE, RADIANCE and ERASE trials had recorded an increase in mortality, rates of myocardial infarction, angina, and heart failure. In the near future, drugs as [beta]-glucans, Apo-A1 mimetic peptides, and ACAT inhibitors, are the new promises to treat this condition.
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Carotid Intima-Media Thickness: Knowledge and Application to Everyday Practice
Postgraduate Medicine, 11/25/09
HDL cholesterol response to growth hormone replacement is associated with common cholesteryl ester transfer protein gene variation (-629C>A) and modified by glucocorticoid treatment
European Journal of Endocrinology, 11/24/09
Dyslipidemia in Chronic Kidney Disease: Managing a High-Risk Combination
Postgraduate Medicine, 11/24/09
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
The Lancet, 11/30/09
Persistent Diastolic Dysfunction Late After Valve Replacement in Severe Aortic Regurgitation
Circulation, 11/30/09
Effect of Lovastatin on Primary Prevention of Cardiovascular Events in Mild CKD and Kidney Function Loss: A Post Hoc Analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study
American Journal of Kidney Diseases, 11/30/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
The Lancet, 11/30/09
Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness
New England Journal of Medicine, 11/30/09
Effect of Lovastatin on Primary Prevention of Cardiovascular Events in Mild CKD and Kidney Function Loss: A Post Hoc Analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study
American Journal of Kidney Diseases, 11/30/09